Antibody specific to thioredoxin reductase as a new biomarker for serodiagnosis of invasive aspergillosis in non-neutropenic patients

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 938-943

  Shi, Li ning ^a,b   Li, Fang qiu ^b   Lu, Jing fen ^b   Kong, Xiao xiang ^b   Wang, Shi qin ^b   Huang, Mei ^b   Shao, Hai feng ^b   Shao, Shi he ^a  

^a JIANGSU UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Antibody detection; Aspergillus fumigatus; Invasive aspergillosis; Non neutropenic patients; Serodiagnosis; Thioredoxin reductase GliT

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; GALACTOMANNAN; ITRACONAZOLE; MICAFUNGIN; THIOREDOXIN REDUCTASE; VORICONAZOLE;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; ASPERGILLUS FUMIGATUS; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INVASIVE ASPERGILLOSIS; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, FUNGAL; ANTIBODY SPECIFICITY; ASPERGILLOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MANNANS; MIDDLE AGED; NEUTROPENIA; RABBITS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; THIOREDOXIN-DISULFIDE REDUCTASE;

ANIMALIA; ASPERGILLUS FUMIGATUS; FUNGI; ORYCTOLAGUS CUNICULUS;

EID: 84862798705     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.02.011     Document Type: Article

References (28)

1. Bulpa P.A., Dive A.M., Garrino M.G., et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?. Intensive Care Med 2001, 27:59-67.
2. Garnacho-Montero J., Amaya-Villar R., Ortiz-Leyba C. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005, 9:R191-R199.
3. Meersseman W., Vandecasteele S.J., Wilmer A., Verbeken E., Peetermans W.E., Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004, 170:621-625.
4. Vandewoude K., Blot S., Benoit D., Depuydt P., Vogelaers D., Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 2004, 59:251-257.
5. Vandewoude K.H., Blot S.I., Benoit D., Colardyn F., Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 2004, 56:269-276.
6. Vandewoude K.H., Blot S.I., Depuydt P. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006, 10:R31.
7. Dimopoulos G., Piagnerelli M., Berre J., Salmon I., Vincent J.L. Post mortem examination in the intensive care unit: still useful?. Intensive Care Med 2004, 30:2080-2085.
8. Roosen J., Frans E., Wilmer A., Knockaert D.C., Bobbaers H. Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings. Mayo Clin Proc 2000, 75:562-567.
9. Ader F., Nseir S., Le Berre R., et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005, 11:427-429.
10. Chen K.Y., Ko S.C., Hsueh P.R., Luh K.T., Yang P.C. Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest 2001, 120:177-184.
11. Prodanovic H., Cracco C., Massard J., et al. Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol 2007, 7:2.
12. Khasawneh F., Mohamad T., Moughrabieh M.K., Lai Z., Ager J., Soubani A.O. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 2006, 21:322-327.
13. Sessa A., Meroni M., Battini G., et al. Nosocomial outbreak of Aspergillus fumigatus infection among patients in a renal unit?. Nephrol Dial Transplant 1996, 11:1322-1324.
14. Sahlen A.O., Suvarna S.K., Wilkie M.E. A case of invasive pulmonary aspergillosis in renal failure. Nephrol Dial Transplant 2004, 19:2687.
15. ter Maaten J.C., Golding R.P., Strack van Schijndel R.J., Thijs L.G. Disseminated aspergillosis after near-drowning. Neth J Med 1995, 47:21-24.
16. Vieira D.F., Van Saene H.K., Miranda D.R. Invasive pulmonary aspergillosis after near-drowning. Intensive Care Med 1984, 10:203-204.
17. Leroy P., Smismans A., Seute T. Invasive pulmonary and central nervous system aspergillosis after near-drowning of a child: case report and review of the literature. Pediatrics 2006, 118:e509-e513.
18. Trof R.J., Beishuizen A., Debets-Ossenkopp Y.J., Girbes A.R., Groeneveld A.B. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med 2007, 33:1694-1703.
19. Hearn V.M., Pinel C., Blachier S., Ambroise-Thomas P., Grillot R. Specific antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methods. J Clin Microbiol 1995, 33:982-986.
20. Chan C.M., Woo P.C., Leung A.S., et al. Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol 2002, 40:2041-2045.
21. Woo P.C., Chan C.M., Leung A.S., et al. Detection of cell wall galactomannoprotein Afmp1p in culture supernatants of Aspergillus fumigatus and in sera of aspergillosis patients. J Clin Microbiol 2002, 40:4382-4387.
22. Schwienbacher M., Weig M., Thies S., Regula J.T., Heesemann J., Ebel F. Analysis of the major proteins secreted by the human opportunistic pathogen Aspergillus fumigatus under in vitro conditions. Med Mycol 2005, 43:623-630.
23. Sarfati J., Monod M., Recco P., et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 2006, 55:279-291.
24. Shi L.N., Li F.Q., Huang M., et al. Immunoproteomics based identification of thioredoxin reductase GliT and novel Aspergillus fumigatus antigens for serologic diagnosis of invasive aspergillosis. BMC Microbiol 2012, 12:11.
25. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
26. Mennink-Kersten M.A., Donnelly J.P., Verweij P.E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004, 4:349-357.
27. Dagenais T.R., Keller N.P. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 2009, 22:447-465.
28. Wong S.S., Wong K.H., Hui W.T., et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 2001, 39:4535-4540.